Kenvue, the maker of Listerine, has named an interim CEO and is exploring strategic alternatives. The consumer health company has not provided further details on the interim CEO or the strategic alternatives it is considering. Kenvue has faced challenges in recent years, including declining sales and a failed attempt to merge with competitor Church & Dwight.
Kenvue Inc. (NYSE: KVUE), the global consumer health company known for brands like Listerine, has announced significant changes in its leadership and strategic direction. On July 14, 2025, the company appointed Kirk Perry as interim CEO, effective immediately, and initiated a comprehensive review of strategic alternatives to unlock shareholder value.
The appointment of Mr. Perry, a seasoned consumer products and brand strategist with over 30 years of experience, comes after Thibaut Mongon's departure from the company. Perry joins Kenvue with a proven track record in leading businesses across consumer and technology sectors. He previously served as President and CEO of Circana and held various leadership roles at Procter & Gamble.
The company's strategic review, led by a Strategic Review Committee, will consider a broad range of potential alternatives, including optimizing the brand portfolio and enhancing operational performance. The review is being advised by Centerview Partners and McKinsey & Company. Kenvue expects to update shareholders on the progress of this review.
In addition to the strategic review, Kenvue has reported select preliminary financial results for the second quarter ended June 29, 2025. The company reported a net sales change of 4.0% and an organic sales change of 4.2%. Adjusted diluted earnings per share increased from $0.21 to $0.22, while adjusted net income grew from $0.28 to $0.29. The full financial results and the revised full-year 2025 outlook will be reported on August 7, 2025.
Kenvue has faced challenges in recent years, including declining sales and a failed attempt to merge with competitor Church & Dwight. The company's actions to appoint a new CEO and initiate a strategic review aim to address these challenges and position the company for future success.
References:
[1] https://investors.kenvue.com/financial-news/news-details/2025/Kenvue-Announces-CEO-Transition-and-Actions-to-Unlock-Shareholder-Value/default.aspx
Comments
No comments yet